Vaccines Market Research Reports & Industry Analysis
Because of the large number of deadly diseases that have been eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements of the 20th century. Key issues in the global vaccine market today include unequal access to vaccines, supply chain disruptions, the use of vaccines to prevent pandemics and address bioterrorism, technological innovations, and vaccine hesitancy. Learn more about this critical field with the comprehensive selection of vaccine market research reports available on MarketResearch.com.
New Vaccines Market Data and Insights
- Find data on vaccine market size segmented by region, technology, distribution channel, type, route of administration, and disease.
- Gain a deep understanding of vaccine industry dynamics, market structure, growth outlook, and competitive landscape.
- Learn about influential government initiatives and new vaccination technologies that have highly promising results.
Your Source for Expert Data and Analysis
MarketResearch.com is a trusted research partner, backed by over two decades of experience. Our clients include top investment banks, management consulting firms, and leading multinational companies within the Fortune 500. Our team of research specialists is dedicated to guiding you at every step, ensuring you have the resources and insights you need to answer your toughest research questions. Browse our full list of vaccines industry reports today.
Vaccines Industry Research & Market Reports
-
Oral Typhoid Vaccine Market
... Residents of Endemic Areas, Healthcare Workers), By geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Typhoid fever, an infectious disease caused by the bacterium Salmonella typhi, remains a significant global health ... Read More
-
Travel Vaccines Global Market Report 2023 Including: 1) By Disease: Hepatitis A; Diphtheria, Pertussis, And Tetanus (DPT); Yellow Fever; Typhoid; Hepatitis B; Measles And Mumps; Rabies; Meningococcal; 2) By Composition: Mono Vaccines; Combination Vaccines 3) By Booking Channel: Online Booking; In-Person Booking 4) By Application: Domestic Travel; Outbound Travel Covering: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA
... Channel: Online Booking; In-Person Booking4) By Application: Domestic Travel; Outbound TravelCovering: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA Travel Vaccines Global Market Report 2023 from The Business Research Company ... Read More
-
Neoantigen Targeted Therapies Global Market Report 2023 Including: 1) By Type: Monotherapy; Combination Therapy 2) By Immunotherapy Type: DNA Or RNA-Based Vaccines; Protein-Based Vaccines; Dendritic Cell Vaccines; TIL-Based Therapies 3) By Target Disease Indication: Colorectal Cancer; Renal Cell Carcinoma; Non-Small Cell Lung Cancer; Bone Cancer; Gynecological Cancer 4) By Route of Administration: Intradermal; Intravenous; Subcutaneous 5) By Application: Medical Research Institution; Hospital; and Clinic Covering: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly and Company
... Cell Carcinoma; Non-Small Cell Lung Cancer; Bone Cancer; Gynecological Cancer4) By Route of Administration: Intradermal; Intravenous; Subcutaneous5) By Application: Medical Research Institution; Hospital; and ClinicCovering: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers ... Read More
-
Influenza Vaccines Global Market Report 2023 Including: 1) By Vaccine Type: Inactivated; Live Attenuated 2) By Valency: Quadrivalent; Trivalent 3) By Route Of Administration: Injection; Nasal Spray 4) By Age Group: Pediatric; Adult 5) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply Covering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC.
... Pharmacies; Government And Institutional SupplyCovering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC. Influenza Vaccines Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Anti-infective Vaccines Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increased Occurrence of New and Re-emerging Infectious Illnesses Driving Market ... Read More
-
Fill Finish Manufacturing Global Market Report 2023 Including: 1) By Product: Consumables; Instruments 2) By Modality: Recombinant Proteins; Monoclonal Antibodies; Vaccines; Cell Therapies; Viral Gene Therapies; Non-Viral Gene Therapies 3) By End-User: Contract Manufacturing Organizations; Biopharmaceutical Companiess Covering: Johnson And Johnson; AbbVie Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson And Company; Baxter International Inc.
... Johnson And Johnson; AbbVie Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson And Company; Baxter International Inc. Fill Finish Manufacturing Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with ... Read More
-
RNA Therapeutics and RNA Vaccines Market, 2023-2035 (Forecasted Estimates)
... and is expected to grow at compounded annual growth rate (CAGR) of 50% during the forecast period (2026-2035). In the past few years, RNA based therapeutics have emerged as one of the key therapeutic modalities ... Read More
-
RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) - Global Forecast to 2028
... projected to grow from USD 13.7 billion in 2023 to USD 18.0 billion by 2028 at a CAGR of 5.6%. The key factors driving the overall market growth include an increase in the number of ... Read More
-
Biotechnology Contract Manufacturing Market by Service (Manufacturing, Fill Finish, Packaging), Type (Drug Substance, Drug Product), Scale, Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecasts to 2028
... manufacturing market is estimated to reach USD 24.8 billion by 2028 from USD 16.6 billion in 2023, at a CAGR of 8.3% during the forecast period of 2023 to 2028. The growth of this market ... Read More
-
Global Toxoid Vaccine Market - 2023-2030
... period 2023-2030. Toxoid vaccines use toxoids (as antigens) to induce an immune response in protecting against diseases caused by toxins secreted by specific bacteria. Compared to other vaccines, toxoid vaccines are more stable and less ... Read More
-
Clinical Trials Market by Phase (Phase I, II, III), Service Type (Laboratory, Analytical Testing, Patient Recruitment, Protocol Designing), Therapeutic Area (Oncology, Cardiology, Neurology), and Application (Vaccine, mAbs, CGT) - Global Forecast to 2028
... clinical trials market is projected to reach USD 73.2 billion by 2028 from USD 48.2 billion in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028. The growth of this ... Read More
-
North America Travel Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028. Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. They ... Read More
-
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), Route of administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Type ( Human vaccine , Veterinary vaccine) - Global Forecast to 2028
... size is projected to reach USD 1.2 billion by 2028 from USD 0.8 billion in 2023, at a CAGR of 6.9% during the forecast period. Factors such as as the rising prevalence of infectious diseases, ... Read More
-
Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 12.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.61% during 2023-2028. Cancer is a malignant tumor caused by the uncontrollable growth of abnormal cells in the body. It can be treated ... Read More
-
Microcarrier Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... is a help matrix, which lets in the increase of adherent cells in bioreactors. In the large-scale business production of biologics and vaccines, microcarriers are employed to grow virus-generating or protein-producing adherent cellular populations. As ... Read More
-
Biologics Outsourcing Market Size - By Product (Antibodies, Recombinant Proteins, Vaccines), Service (Cell & Process Development, Analytical Testing), Source (Mammalian, Microorganism), Application, End-user, Global Forecast, 2023 - 2032
... expand at 14.1% CAGR from 2023-2032 driven by the increasing focus on R&D collaborations between biopharmaceutical companies and outsourcing partners. The rising complexities of biological drug development and production along with collaborative partnerships are enabling ... Read More
-
Global Therapeutic Vaccines Market, 2022-2035
... is worth highlighting that six out of ten individuals in the US are anticipated to be suffering from at least one chronic disease. Specifically, such patients are required to take medication on a daily basis, ... Read More
-
mRNA Therapeutics and Vaccines Market (2nd Edition), 2022-2035
... for protein synthesis are transferred from a strand of DNA to the ribosomes, where these instructions are translated and processed into functional proteins. Q1. How is the research and development (R&D) activity evolving in the ... Read More
-
Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Analysis By End User (Adult and Maternal & Pediatric), By Type (Vaccine & Antibody), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030
... up to 2030 RSV, or respiratory syncytial virus, is a common respiratory virus that causes mild, cold-like symptoms in both the upper and lower respiratory tracts. RSV can be harmful, especially in infants and the ... Read More
-
Global COVID-19 Vaccines & Therapeutics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... has gone into combating the SARS-CoV-2 virus and COVID-19 disease. In late 2019, a mysterious pneumonia-like illness emerged in China that caught the attention of the world’s health experts and scientists. The illness quickly spread ... Read More
-
Cancer Vaccines Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Adoption of Technology in Drug Development to Create Market Opportunities ... Read More
-
Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines in Clinical Development, Size, Share, Trends, Major Deals and Recent Developments - Forecast to 2030
... is projected to reach US$ 10.9 Billion by 2030. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The Centers for Disease Control and Prevention (CDC) recommends routine seasonal influenza vaccination ... Read More
-
India Malaria Vaccine Market Assessment, By Agent [Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae, Plasmodium Ovale, Plasmodium Knowlesi], By Stage Targeted [Pre-erythrocytic vaccines, Erythrocytic vaccines, Transmission-blocking vaccines, By Type of Vaccine [Whole Organism Vaccine and Protein Subunit Vaccine], By Technology [mRNA and Recombinant], By Route of Administration [Intramuscular, Subcutaneous, Intradermal, Others], By End-user [Hospitals, Specialty clinics, Homecare, Others], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy Government, Non-Governmental Organisations], By Region, By Opportunities and Forecast, FY2017-FY2031
... to the WHO, India had a significant share in global malaria cases and deaths in 2021. India accounted for about 4% of global malaria cases and 7% of malaria deaths in 2021. The India malaria ... Read More
-
COVID-19 Vaccines Market Size, Trends and Analysis by Disease Overview, Epidemiology, Unmet Needs and Opportunities, Therapeutic Landscape, Pipeline Assessment, Clinical Trial Strategies and Forecast to 2026
... COVID-19 market including disease overview, epidemiology, current treatment options, unmet needs and opportunities, R&D strategies, pipeline assessment, and market outlook. COVID-19 is a disease caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 ... Read More
-
Europe Veterinary Vaccine Market, By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines); By Animal Type (Livestock (Poultry, Aqua, Ruminants, Swine), Companion (Canine, Feline)); By Route of Administration (Subcutaneous, Intramuscular, Intranasal); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe), Competitive Landscape & Forecast, 2019–2029
... By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe), Competitive Landscape & Forecast, 2019–2029 Europe Veterinary Vaccine Market Size Set to Reach USD 4.5 Billion by 2029 Europe veterinary vaccine ... Read More
Research Assistance
